The developing chicken blastoderm can be temporarily maintained in dormancy below physiological zero temperature. However, prolonged preincubation egg storage impairs normal morphological and physiological development of embryos in a potential example of fetal programming (in this case, “embryonic programming”). We investigated how preincubation egg storage conditions (temperature, duration, hypoxia, and hypercapnia) affects viability, body mass, and physiological variables and functions in day 15 chicken embryos. Embryo viability was impaired in eggs stored for 2 and 3 weeks, with the effects greater at 22°C compared to 15°C. However, embryo size was reduced in eggs stored at 15°C compared with 22°C. Phenotypic change resulting from embryonic programming was evident in the fact that preincubation storage at 15°C diminished hematocrit (Hct), red blood cell concentration ([RBC]), and hemoglobin concentration ([Hb]). Storage duration at 15°C more severely affected the time course (2, 6, and 24 h) responses of Hct, [RBC], and [Hb] to progressive hypoxia and hypercapnia induced by submersion compared with storage duration at 22°C. The time‐specific regulation of acid–base balance was changed progressively with storage duration at both 22 and 15°C preincubation storages. Consequently, preincubation egg storage at 22°C resulted in poor viability compared with eggs stored at 15°C, but size and physiological functions of embryos in eggs stored for 1–2 weeks were worse in eggs stored in the cooler than stored under room conditions. Avian eggs thus prove to be useful for examining developmental consequences to physiology of altered preincubation thermal environment in very early stages of development (embryonic programming).
An increase in both vascular circumferential tension and shear stress in the developing vasculature of the chicken embryo has been hypothesized to stimulate angiogenesis in the developing peripheral circulation chorioallantoic membrane (CAM). To test this hypothesis, angiogenesis in the CAM, development, and growth were measured in the early chicken embryo, following acute and chronic topical application of the purely bradycardic drug ZD7288. At hour 56, ZD7288 reduced heart rate (f H ) by ∼30% but had no significant effect on stroke volume (∼ mL), collectively resulting in a significant fall in 0.19 ע 0.2 cardiac output (CO) from ∼ to mL min Ϫ1 . Mean 27 ע 3 ע81 2 f H at 72 h of development was similarly significantly lowered by acute ZD7288 treatment (250 mM) to beats min Ϫ1 , 128 ע 0.3 compared with and beats min Ϫ1 in con-174.5 ע 0.3 174.7 ע 0.8 trol and Pannett-Compton (P-C) saline-treated embryos, respectively. Chronic dosing with ZD7288-and the attendant decreases in f H and CO-did not change eye diameter or cervical flexion (key indicators of development rate) at 120 h but significantly reduced overall growth (wet and dry body mass decreased by 20%). CAM vessel density index (reflecting angiogenesis) measured 200-400 mm from the umbilical stalk was not altered, but ZD7288 reduced vessel numbers-and therefore vessel density-by 13%-16% more distally (500-600 mm from umbilical stalk) in the CAM. In the ZD7288-treated embryos, a decrease in vessel length was found within the second branch order (∼300-400 mm from the umbilical stock), while a decrease in vessel diameter was found closer to the umbilical stock, beginning in the first branch order (∼200-300 mm). Paradoxically, chronic application of P-C saline also reduced peripheral CAM vessel density index at 500 and 600 mm by 13% and 7%, respectively, likely from washout of local angiogenic factors. In summary, decreased f H with reduced CO did not slow development rate but reduced embryonic growth rate and angiogenesis in the CAM periphery. This study demonstrates for the first time that different processes in the ontogeny of the early vertebrate embryo (i.e., hypertrophic growth vs. development) have differential sensitivities to altered convective blood flow.
Variations from a relative humidity (RH) of ∼50–60% can unfavorably alter chicken embryo development, but little is known of whether the embryo can mitigate these effects through physiological regulation. We examined effects of Low RH (25–35%), and High RH (85–93%) compared to Control RH (50–60%) on hatchability, embryonic growth, hematology and blood gases and pH. Mean hatchability was not affected by RH. Yet, Low RH decreased wet body mass of advanced embryos (days 17–19; d17-19), with lowered body water content compared with embryos of Control and High RH. However, dry body mass of developing (d11-19) embryos was not different between the three RH groups. Mean blood osmolality across development was higher in Low RH embryos and lower in High RH embryos compared with Control embryos. Mean blood lactate was higher in both Low and High RH embryos compared to Control embryos. Unexpectedly, hematological respiratory variables (Hct, [RBC], MCV, [Hb]) and blood gas variables (Po2, Pco2, pH, [HCO3−]) across development were not affected by RH. Mean wet body mass at hatch (d20-22) was larger in High RH embryos compared with Low RH embryos, but mean wet and dry body mass upon euthanasia on d22 was unaffected. The ability of the three populations to physiologically regulate blood respiratory variables and blood acid-base balance was then examined by observing their responses to intrinsic hypoxemia and hypercapnia created by controlled partial egg submersion in water. Hct and [RBC] responses were less disturbed by submersion in High RH embryos compared with both Control and Low RH embryos, which showed major disturbance. Acid-base regulatory responses did not differ between RH groups. We conclude that, while different incubation RHs cause large differences in tissue water content and body mass, most hematological and acid-base regulatory capabilities are regulated near Control values.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.